GLPwatch
Trials (2036)
Page 10 of 34.
- Safety and Tolerability of Liraglutide in Healthy Male Volunteers
- A Study to Evaluate ITCA 650 Compared to Sitagliptin for the Treatment of Type 2 Diabetes
- A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight
- The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a)
- GLP-1 and Non-exercise Activity Thermogenesis in RHZ
- A Clinical Study to Investigate if SAR425899 Binds to the Liver and Pancreas in Overweight to Obese Type 2 Diabetes Mellitus Patients
- A Clinical Trial Investigating the Comparison of Three Different Concentrations of NN9535 in Healthy Male Subjects
- A Study of LY3025876 in Participants With Diabetes
- Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh
- Effects of Exenatide on Overweight Adolescents With Prader-Willi Syndrome
- Study on the Efficacy and Safety of PLLA Injections for Improving Facial Laxity Following GLP-1 Analog Therapy
- GENETIC VARIABILITY TO GLP1 TREATMENT
- Effects of GH and Lirglutide on AgRP
- Safety and Effectiveness of Tirzepatide in Patients With Obesity at Hospital de Clínicas, Paraguay
- A Pilot Study of the Effects on Sleep Disordered Breathing (SDB) When Using the Drug Liraglutide for 4 Weeks
- A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes
- A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease
- A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities
- GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
- Study to Explore the Safety and Efficacy of NT-0796 as an Adjunct to Semaglutide in Participants With Obesity (RESOLVE-2)
- A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity
- Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD Alone
- Liraglutide to Improve corONary Haemodynamics During Exercise streSS
- Effect of Liraglutide on Neural Responses to High Fructose Corn Syrup in Individuals With Obesity.
- A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in United Kingdom, as Part of Local Clinical Practice (SURE UK)
- Biomarkers in Obese Patients With Knee Osteoarthritis; Weight Maintenance
- Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in Adolescents
- Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes
- Investigation of the Relationship Between Peripheral and Central Metabolic Changes Induced by GLP-1 Agonists
- Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetes
- GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy (GETGOAL-MONO Japan LTS)
- Efficacy and Safety of Liraglutide on Body Weight in Obese Subjects or Overweight Subjects With Co-morbidities
- Semaglutide Treatment On Coronary Progression
- A Study of IBI362 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)
- The Effects of Semaglutide on Body Composition and Performance in Military Personnel
- To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes
- Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
- Effects of GLP1-RA on Ectopic Fat Deposition in Chronic Kidney Disease
- Effects of Glucagon-like-Peptide-1 Analogues on Sexuality
- Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared to Insulin Alone in Japanese Subjects With Type 2 Diabetes
- Low-Dose Semaglutide for Weight Loss in Obese Non-Diabetic Pakistani Adults
- Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 Analogue
- SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity
- Oral vs. Subcutaneous Semaglutide in Type 2 Diabetes Mellitus
- A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight
- A Research Study Comparing the Effect of Different Dosing Conditions on Blood Levels of Semaglutide in a New Tablet Composition in Healthy Participants
- GLP-1 RAs in Patients With Polycystic Ovary Syndrome (PCOS)
- Emulating the PIONEER6 Diabetes Trial Using Healthcare Claims
- Research Study Comparing a New Medicine Semaglutide to Liraglutide in People With Type 2 Diabetes
- Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in East Asian People Who Are Overweight or Living With Obesity
- GLP-1 Agonism Stimulates Browning of Subcutaneous White Adipose Tissue in Obesity Men
- Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Various Degrees of Impaired Renal Function
- Antigen-Lipid-Driven Monoclonal Gammopathies Targeting Epicardial Fat
- A Study to Evaluate the Effect of Ranolazine on Postprandial Glucagon in Subjects With Type 2 Diabetes.
- Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
- Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome
- GLP-1 Response and Effect in Individuals With Obesity Causing Genetic Mutations
- Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who Are Either Obese or Overweight With Weight-Related Comorbidities (SURMOUNT-1)
- Impact of Semaglutide Withdrawal on Cardiometabolic Profile and Physiology of Energy Balance: Recovery Effects After Semaglutide Termination
- Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Metformin and Digoxin in Healthy Subjects